Functional expression of the serotonin 5-HT 7 receptor in human glioblastoma cell lines

British Journal of Pharmacology

Volumn 143, Issue 3, 2004, Pages 404-410

  Mahé, Cécile ^a   Bernhard, Michel ^a   Bobirnac, Ionel ^a   Keser, Corinna ^a   Loetscher, Erika ^a   Feuerbach, Dominik ^a   Dev, Kumlesh K ^a   Schoeffter, Philippe ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

5 HT 7 receptor; Astrocytes; Glial cells; Human glioblastoma; SB 269970

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; 5 CARBAMOYLTRYPTAMINE; 5 METHOXYTRYPTAMINE; CYCLIC AMP; GENOMIC DNA; MESSENGER RNA; SEROTONIN; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST;

ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GENE AMPLIFICATION; GLIA CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; NERVE CELL CULTURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; WESTERN BLOTTING;

5-METHOXYTRYPTAMINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; PROTEIN ISOFORMS; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN;

EID: 7044221809     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705936     Document Type: Article

References (33)

1. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 48-58.
2. 7 receptor activation decreases slow afterhyperpolarization amplitude in CA3 hippocampal pyramidal cells. J. Pharmacol. Exp. Ther., 294, 672-679.
3. 7) positively linked to adenylate cyclase. J. Biol. Chem., 268, 23422-23426.
4. 7 receptors in the mouse suprachiasmatic nucleus. J. Compar. Neurol., 432, 371-388.
5. BOESS, F.G. & MARTIN, I.L. (1994). Molecular biology of 5-HT receptors. Neuropharmacology, 33, 275-317.
6. 7 receptor-mediated depolarization in the anterodorsal thalamus. I. Pharmacological characterization. J. Pharmacol. Exp. Ther., 297, 395-402.
7. COHEN, Z., BOUCHELET, I., OLIVIER, A., VILLEMURE, J.G., BALL, R., STANIMIROVIC, D.B. & HAMEL, E. (1999). Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacologic characterization. J. Cereb. Blood Flow Metabol., 19, 908-917.
8. 7 receptor: orphan found. Trends Pharmacol. Sci., 18, 104-107.
9. 2A receptor-activated cascade in rat C6 glioma cells. Neuroscience, 69, 1119-1131.
10. 7 receptors modulate synchronized network activity in rat hippocampus. Neuropharmacology, 42, 82-92.
11. 7 receptors. J. Physiol., 541, 453-465.
12. 7 receptor antagonist. Br. J. Pharmacol., 130, 539-548.
13. 7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J. Neurochem., 68, 1372-1381.
14. HIRST, W.D., PRICE, G.W., RATTRAY, M. & WILKIN, G.P. (1997). Identification of 5-hydroxytryptamine receptors positively coupled to adenylyl cyclase in rat cultured astrocytes. Br. J. Pharmacol., 120, 509-515.
15. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, F.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-203.
16. HUNEYCUTT, B.S. & BENVENISTE, E.N. (1995). Regulation of astrocyte cell biology by the cAMP/protein kinase A signaling pathway. Adv. Neuroimmunol., 5, 261-269.
17. 7(b)). Br. J. Pharmacol., 122, 126-132.
18. 7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution, Naunyn-Schmiedeberg's Arch. Pharmacol., 363, 620-632.
19. 7 antagonist: (R)-3-(2-(2-(4-methylpiperin- 1-yl)-ethyl)pyrrolidine-1-sulfonyl)phenol (SB-269970). J. Med. Chem., 43, 342-345.
20. 7) implicated in the regulation of mammalian arcadian rhythms. Neuron. 11, 449-458.
21. MEYERHOF, W., OBERMÜLLER, F., FEHR, S. & RICHTER, D. (1993). A novel rat serotonin receptor: primary structure, pharmacology, and expression pattern in distinct brain regions. DNA Cell Biol., 12, 401-409.
22. PLASSAT, J.L., AMLAIKI, N. & HEN, R. (1993). Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol., 44, 229-236.
23. RANSOM, B., BEHAR, T. & NEDERGAARD, M. (2003). New roles for astrocytes (stars at last). Trends Neurosci., 26, 520-522.
24. 7) activating cAMP formation. Proc. Natl. Acad. Sci. U.S.A., 90, 8547-8551.
25. 1A receptors: considerations on receptor effector coupling across systems. Neuropharmacology, 36, 429-437.
26. 1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells. Fund. Clin. Pharmacol., 13, 484-489.
27. 7 receptors in human vascular smooth muscle cells. Br. J. Pharmacol., 117, 993-994.
28. 7 serotonin receptor subtype. J. Biol. Chem., 268, 18200-18204.
29. 7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes. J. Pharmacol. Exp. Ther., 279, 1551-1558.
30. 7 receptors. Curr. Drug Targets CNS Neurol. Disord., 3, 81-90.
31. 7 receptors in guinea-pig brain. Br. J. Pharmacol., 115, 107-116.
32. 7 receptor positively coupled to adenylate cyclase. J. Neurochem., 63, 456-464.
33. 7 receptors mediate serotonergic effects on light-sensitive suprachiasmic nucleus neurons. Brain Res., 755, 246-254.